News

GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and ...
There are a lot of unknowns when it comes to medical expenses in retirement. These following steps may help you control costs.
The Official logo of Scale Selling Corporation If anything, this rebrand allows us to serve families better than ever before.” </b ...
Plus: Miami’s scooter boom fizzles amid immigration crusade, and judge rejects attempt to end standards for detained migrant ...
Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...
Novo Nordisk cuts prices. In a pair of press releases this morning, Novo announced it's cutting the cash cost for 0.5 mg, 1 ...
Novo Nordisk A/S innovation and growth continue to shine. Now, it has a partnership with GoodRX Holdings. Click for my ...
Teladoc Health has acquired Australian virtual care provider Telecare as the telehealth company looks to bolster its international presence. Financial terms of the deal weren’t disclosed, and the ...
President Trump launches bold artificial intelligence strategy to counter Chinese technological dominance and secure America's economic future ...
Adverse policy actions and an unsustainable business model have left the abortion provider struggling to operate.
Phreesia is on track to meet FY26 revenue targets, driven by steady client growth and strong average revenue per client.
GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of Novo Nordisk's (NVO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss, at ...